申请人:Targegen, Inc.
公开号:EP2543376A1
公开(公告)日:2013-01-09
The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases.
本发明提供了具有式(I)的苯并三嗪化合物。本发明的苯并三嗪化合物能够抑制激酶,如 Src 激酶家族的成员,以及其他各种特定的受体和非受体激酶。